Device for managing eyelid drooping

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a feedback-enabled magnetic device designed to temporarily manage blepharoptosis, a condition characterized by drooping eyelids. The device uses near-infrared light sensors and a magnetic actuator to lift the paralytic upper eyelid and restore blink symmetry. Participants will undergo assessments to measure the effectiveness of the device in improving eyelid height and reducing symptoms such as visual obstruction and discomfort. The study aims to compare outcomes between patients using the device and those who have undergone surgical interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with ptosis; they are capable of understanding and complying with protocol requirements
* Aged 18 years old or older

Exclusion Criteria:

* Upper eyelid scar, contracture, or fibrosis due to previous surgical intervention(s)
* Patients with psychiatric (or mental) disorders; they are unable to cooperate or follow the study procedure
* Children younger than 18 years of age

Where it's running

• E-Da Hospital
  Kaohsiung City, Taiwan Recruiting
• Shin Kong Wu Ho-Su Memorial Hospital
  Taipei, Taiwan Recruiting

Study contacts

• Study coordinator: Ching-Feng Lien, MD, PhD
• Email: lien980206@yahoo.com.tw
• Phone: 886-975106033

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blepharoptosis After Repeated Anti-VEGF Injections in One Eye

  This study tests whether repeated intravitreal anti-VEGF injections in one eye affect eyelid position compared with the untreated fellow eye.

  Recruiting Fatih Sultan Mehmet Training and Research Hospital · Istanbul · NCT07821450

• Evaluating a new eye drop treatment for droopy eyelids in Chinese patients

  This study is testing a new eye drop treatment for droopy eyelids to see if it helps Chinese patients who currently have no medication options.

  Recruiting at 23 sites Phase 3 Santen Pharmaceutical Co., Ltd. · Hefei, Anhui and 22 other locations · NCT06683651

• Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea

  This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.

  Recruiting E-DA Hospital · Kaohsiung City · NCT07921329

• Using AI and Endocuff Vision to Improve Colonoscopy Results

  This study is testing if using artificial intelligence with a special tool called Endocuff can help doctors find more polyps during colonoscopy in adults over 20.

  Recruiting E-DA Hospital · Kaohsiung City · NCT05863208

• Investigating the best biopsy methods for Barrett's Esophagus

  This study is testing different biopsy methods to see which one works best for finding early signs of Barrett's Esophagus in patients, especially in Asian populations.

  Recruiting E-DA Hospital · Kaohsiung City · NCT05818072

• Using radiofrequency ablation to prevent recurrence of esophageal cancer after surgery

  This study tests whether using radiofrequency ablation can help prevent new esophageal cancer from coming back in patients who have already had surgery for early-stage cancer.

  Recruiting E-DA Hospital · Kaohsiung City · NCT03183115

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.